首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardiovascular therapeutics

缩写:CARDIOVASC THER

ISSN:1755-5914

e-ISSN:1755-5922

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引940
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Wei Xu,Cheng-Yuan Yu,Ding-Yu Wang et al. Wei Xu et al.
Atrial autonomic nerve system (ANS) remodeling plays an important role in atrial fibrillation (AF). Mineralocorticoid receptor antagonists (MRAs) have been proved to be effective in preventing atrial structural remodeling. However, the effe...
Ying Qian,Fang Yi Ying Qian
Background: Sunitinib (SU) is used to treat kidney cancer. However, it can also cause cardiotoxicity. This study is performed to investigate whether rivaroxaban (RIV) attenuates SU-induced cardiotoxicity (SIC). Methods and Materials: AC16 c...
Xiaolin Zhang,Miaohan Qiu,Kun Na et al. Xiaolin Zhang et al.
Background: The tryptophan/kynurenic acid (KYNA) pathway plays a crucial role by modulating inflammation, oxidative stress, and immune activation. The clinical value of tryptophan metabolites in the KYNA pathway for the early diagnosis and ...
Miaomiao Qi,Qiongying Wang,Runmin Sun et al. Miaomiao Qi et al.
Oxidative stress and mitochondrial dysfunction play critical roles in the pathology of cardiovascular diseases. However, the effects of Astragaloside IV (As-IV) on mitochondrial function remain unclear. This study is aimed at evaluating the...
Qing Yan,Yide Yuan,Jiaqi Liang et al. Qing Yan et al.
Background: The standard oral dose of rivaroxaban for nonvalvular atrial fibrillation (NVAF) patients with a creatinine clearance rate (CrCl) ≥ 50 mL/min is 20 mg/day in Europe and 15 mg/day in Japan. In the real world, low-dosing (10 mg/d...
Kay Weipert,Holger Nef,Sandra Voss et al. Kay Weipert et al.
Aims: The aim of the present study was to investigate the inhibition of classically activated macrophages in myocardial infarction (MI) under the influence of the chemokine (C-C motif) receptor 2 (CCR2) antagonist propagermanium (PPG). Meth...
Yijia Shao,Jiapan Sun,Xiang Liu et al. Yijia Shao et al.
Background and Aims: Trimethylamine-N-oxide (TMAO) is recognized as a novel marker and mediator of atherosclerotic cardiovascular disease (ASCVD). Endothelial progenitor cells (EPCs) are crucial for maintaining vascular homeostasis. Impaire...
Wanying Li,Ding Wang,Caiyue Lin et al. Wanying Li et al.
Introduction: In clinical practice, patients often avoid or cease statin use due to adverse reactions or noncompliance. To elucidate statin adverse reactions, their variability across diseases, and the factors influencing them, we conducted...
Haitian-Li,Zhijie-Zhang,Yang-Yang et al. Haitian-Li et al.
Background: Arrhythmia after myocardial infarction, a common disease, has a high incidence and lethality in clinical practice, which seriously affects patients' quality of life and survival time. Based on our previous study and available ev...
Christophe Beyls,Thomas Hanquiez,Nicolas Mollet et al. Christophe Beyls et al.
Background: Cardiogenic shock (CS) may lead to a refractory vasoplegic state that requires vasopressin on top of norepinephrine. Vasopressin has been available in France since January 2022. However, data assessing the clinical impact of vas...